Soy isoflavones relieve menopausal hot flashes

This study found that women taking soy isoflavone supplements reported fewer menopausal symptoms — including hot flashes — after one month and continuing through six months of treatment. However, because every woman in the study received the supplement and no group received a dummy pill (placebo), it is impossible to know whether the improvement was caused by the supplement or would have occurred anyway.

• No placebo group: both arms received active treatment; natural symptom improvement over time cannot be separated from a supplement effect
• Unblinded: women knew they were taking the supplement, which amplifies self-reported symptom improvement on questionnaires
• Hot flash claim vs. study scope: the paper measures a composite vasomotor subscale and self-reported frequency was recorded but not analyzed separately — the paper and claim are not properly aligned on the primary outcome of interest
• Hormone levels uncontrolled: endogenous estrogen (E2) was measured at baseline to confirm menopausal status but follow-up hormone levels are not reported or included as covariates in the efficacy models — fluctuations in circulating estrogen over the 6-month study period are therefore unaccounted for
• Subgroup results for cholesterol and bone: emerged from analyses on smaller subsets without correction for multiple tests, making those findings unreliable as standalone evidence
• Product supplied by manufacturer: the supplement was provided free by its maker (Arkopharma), which is a potential conflict of interest